12 Health Care Stocks Moving In Wednesday’s Intraday Session
Gainers Geovax Labs (NASDAQ:GOVX) stock moved upwards by 72.1% to $1.91 during Wednesday’s regular session. The company’s market…
Lipocine To Present 52 Week Results From LPCN 1148 Phase 2 Study In Late Breaking Session At EASL Congress 2024
Lipocine Inc. (NASDAQ:LPCN), a biopharmaceutical company, today announced that Phase 2 results on LPCN 1148 in cirrhosis were featured in a late breaking oral presentation at the European Association for the Study
Lipocine Announces Late Breaking Oral Presentation Of Data From The Phase 2 Study Of LPCN 1148 At EASL Congress 2024
Lipocine Inc. (NASDAQ:LPCN), a biopharmaceutical company, today announced that data from the Phase 2 study of LPCN 1148 has been selected for a late breaking oral presentation at the European Association for the Study of
12 Health Care Stocks Moving In Thursday’s Pre-Market Session
Gainers Eliem Therapeutics (NASDAQ:ELYM) stock moved upwards by 51.6% to $4.05 during Thursday’s pre-market session. The market value…
Lipocine Announces Confirmation Of Dosing Regimen For Pivotal Study Of LPCN 1154
Positive clinical study results confirm 48-hour dosing regimen for the pivotal PK studyOn track for Q2-24 pivotal study topline results and planned Q4-24 NDA filing SALT LAKE CITY, Feb. 6, 2024 /PRNewswire/ --
12 Health Care Stocks Moving In Thursday’s Pre-Market Session
Gainers Celularity (NASDAQ:CELU) shares rose 43.4% to $0.27 during Thursday’s pre-market session. The company’s market cap stands at…
Lipocine And Verity Pharma Enter Into License Agreement For TLANDO Franchise In The U.S. And Canada; Lipocine To Receive $11M License Fee; Up To $259M In Development And Commercial Sales Milestones
Lipocine to receive $11 million license feeUp to $259 million in development and commercial sales milestonesTiered royalties on net sales of licensed products up to 18%Commercialization of TLANDO transitions to Verity
Stocks That Hit 52-Week Lows On Thursday
During Thursday's session, 406 companies made new 52-week lows.
Why Willis Towers Watson Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Thursday’s Mid-Day Session
Gainers
Femasys Inc. (NASDAQ: FEMY) gained 54% to $0.55. Femasys reported a notice of allowance for new U.S. patent application covering use of FemBloc for female permanent birth control.
Why Lipocine Stock Is Moving Higher Today?
Lipocine Inc (NASDAQ: LPCN) shares are trading higher after the company released topline results from a Phase 2 clinical study of LPCN 1148, an oral candidate under development for the